Global trend and predictors of non-labelled sacubitril-valsartan dosing: results from IKNOW-HF survey.

Yaseen IF, Farhan HA, Gnanaraj JP, Fukaya H, Prameswari HS, Saldarriaga C, Kemaloğlu Öz T, Elhout SA, Díez-Villanueva P, Costanzo MR, Toma M, Elsheikh Ibrahim NOE, Dakhil ZA, Mewton N, Mullens W, IKNOW-HF investigators Group .

Open source

DOI: 10.1093/eschf/xvag162
Published: 2026-05-01
Container: ESC Heart Fail
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/eschf/xvag162,
  title = {Global trend and predictors of non-labelled sacubitril-valsartan dosing: results from IKNOW-HF survey.},
  author = {Yaseen IF and  Farhan HA and  Gnanaraj JP and  Fukaya H and  Prameswari HS and  Saldarriaga C and  Kemaloğlu Öz T and  Elhout SA and  Díez-Villanueva P and  Costanzo MR and  Toma M and  Elsheikh Ibrahim NOE and  Dakhil ZA and  Mewton N and  Mullens W and  IKNOW-HF investigators Group
.},
  year = {2026},
  journal = {ESC Heart Fail},
  doi = {10.1093/eschf/xvag162},
  url = {https://doi.org/10.1093/eschf/xvag162}
}

RIS

TY  - JOUR
TI  - Global trend and predictors of non-labelled sacubitril-valsartan dosing: results from IKNOW-HF survey.
AU  - Yaseen IF
AU  -  Farhan HA
AU  -  Gnanaraj JP
AU  -  Fukaya H
AU  -  Prameswari HS
AU  -  Saldarriaga C
AU  -  Kemaloğlu Öz T
AU  -  Elhout SA
AU  -  Díez-Villanueva P
AU  -  Costanzo MR
AU  -  Toma M
AU  -  Elsheikh Ibrahim NOE
AU  -  Dakhil ZA
AU  -  Mewton N
AU  -  Mullens W
AU  -  IKNOW-HF investigators Group
.
PY  - 2026
JO  - ESC Heart Fail
DO  - 10.1093/eschf/xvag162
UR  - https://doi.org/10.1093/eschf/xvag162
ER  -

APA

IF, Y., HA, F., JP, G., H, F., HS, P., C, S., T, K. Ö., SA, E., P, D., MR, C., M, T., NOE, E. I., ZA, D., N, M., W, M., & ., I. I. G. (2026). Global trend and predictors of non-labelled sacubitril-valsartan dosing: results from IKNOW-HF survey.. ESC Heart Fail. https://doi.org/10.1093/eschf/xvag162

Source records

europe-pmc · retrieved 2026-09-26T08:13:28.927Z